Literature DB >> 19696297

Mediastinal nodes in patients with non-small cell lung cancer: MRI findings with PET/CT and pathologic correlation.

Dae Wook Yeh1, Kyung Soo Lee, Joungho Han, Chin A Yi, Ho Yun Lee, Myung Jin Chung, Tae Sung Kim.   

Abstract

OBJECTIVE: The purpose of this article is to correlate MRI findings of mediastinal nodes with PET/CT and pathology in non-small cell lung cancer.
CONCLUSION: Malignant nodes show high FDG uptake at PET, or eccentric cortical thickening or obliterated fatty hilum on T2-weighted MRI. Benign nodes (with follicular hyperplasia, sinus histiocytosis, fibrotic micronodules, or calcification) may show high FDG uptake at PET, whereas MRI may help distinguish benign from malignant nodes by showing low signal intensity in nodes on T2-weighted MRI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696297     DOI: 10.2214/AJR.08.2083

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  ¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.

Authors:  Sheng-Chieh Chan; Hung-Ming Wang; Tzu-Chen Yen; Chien-Yu Lin; Shy-Chyi Chin; Chun-Ta Liao; Yau-Yau Wai; Jiun-Jie Wang; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-13       Impact factor: 9.236

2.  Image-guided drug delivery in lung cancer.

Authors:  Timothy S Wiedmann; Tanmoy Sadhukha; Bruce E Hammer; Jayanth Panyam
Journal:  Drug Deliv Transl Res       Date:  2012-02       Impact factor: 4.617

3.  Discrimination of Malignant versus Benign Mediastinal Lymph Nodes Using Diffusion MRI with an IVIM Model.

Authors:  Li-Ping Qi; Wan-Pu Yan; Ke-Neng Chen; Zheng Zhong; Xiao-Ting Li; Kejia Cai; Ying-Shi Sun; Xiaohong Joe Zhou
Journal:  Eur Radiol       Date:  2017-09-19       Impact factor: 5.315

Review 4.  Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging.

Authors:  Jessica C Sieren; Yoshiharu Ohno; Hisanobu Koyama; Kazuro Sugimura; Geoffrey McLennan
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

5.  Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients.

Authors:  Julian M M Rogasch; Ingo G Steffen; Sandra Riedel; Ivayla Apostolova; Heinz Wertzel; H Jost Achenbach; Ferdinand L G A Steinkrüger; Thomas Kalinski; Meinald Schultz; Jens Schreiber; Holger Amthauer; Christian Furth
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

6.  Conventional MRI to detect the differences between mass-like tuberculosis and lung cancer.

Authors:  Li-Ping Qi; Ke-Neng Chen; Xiaohong Joe Zhou; Lei Tang; Yu-Liang Liu; Xiao-Ting Li; Juan Wang; Ying-Shi Sun
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

7.  Magnetic resonance (MR) imaging for tumor staging and definition of tumor volumes on radiation treatment planning in nonsmall cell lung cancer: A prospective radiographic cohort study of single center clinical outcome.

Authors:  Dan Zhao; Qiaoqiao Hu; Liping Qi; Juan Wang; Hao Wu; Guangying Zhu; Huiming Yu
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.